First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma. - Wikidata - awgldk - TriplyDB

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

http://www.wikidata.org/entity/Q35544697

about

Treatment of soft tissue sarcoma: a focus on earlier stages.

P2860

Q30240235-CA4157D1-15B5-4713-948E-3C99C7797283

P2860

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

http://www.wikidata.org/entity/Q35544697

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

@ast

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

@en

type

label

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

@ast

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

@en

prefLabel

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

@ast

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

@en

P1433

Q35544697-61F1F6DC-7D44-4399-859A-BB2A1B2D7F3A

P1476

Q35544697-7003D363-0055-4264-8029-2FA1CB43A816

P2093

Q35544697-1CA946D1-189B-4D7C-8D6E-9571FA89DAB6

Q35544697-2605DA72-7059-4658-BC21-D501ED9BC400

Q35544697-2A9FF75A-41FD-489B-A015-EBAA8D90CEA8

Q35544697-33EA4B10-744F-4E82-924F-AAE8FD419A9B

Q35544697-6B6A229D-7893-4455-B2F6-F148554AD49D

Q35544697-6EC0D509-EACA-43E9-8612-AA28FC9FDA1B

Q35544697-7D57C32F-8778-44EA-A261-46E5156A4755

Q35544697-AC9C73F2-D641-44A0-8A5D-15C0A4AA8D3D

Q35544697-BCED632E-3515-4D00-9DF7-D669D9BF7B6B

Q35544697-CDBA15D2-3EDB-4016-86E1-B0E406152EBF

P2860

Q35544697-026ACA95-4874-4625-ADBA-7502E8CDC490

Q35544697-0997D38E-BFDF-47E6-A71B-395333C050CF

Q35544697-19886952-C101-44EE-A110-DB023EDB7275

Q35544697-20364829-6574-4060-B8C4-61775F0BBE97

Q35544697-22FBE296-3D24-420D-973F-4F31DC991CB7

Q35544697-2453EE7E-C149-4FCD-8B96-430197D12B03

Q35544697-2CE3B776-6B31-45B5-90DB-3D81C3886040

Q35544697-30A5CE9D-E571-4E0D-BDB5-4F2BBCD8A20C

Q35544697-4B940F64-73F1-4BD3-8CB9-56D6AB92F9B6

Q35544697-4D1101F5-EF82-4CF5-86F8-D473B0C45910

P2888

Q35544697-8EFFC563-7FE5-4ABC-85BB-153626385E39

P304

Q35544697-A4004D00-C690-4CBD-8782-BE42BF44D998

P31

Q35544697-D9DF6B7C-CA1A-48DF-BA36-C4BD7F37216C

P356

Q35544697-20A3B61C-4D7C-4B96-978D-5CE6962D6A28

P478

Q35544697-8D229E76-8EBF-4BF7-88D4-17E6520532F4

P50

Q35544697-9F3081FD-31FE-474A-B00F-45D4CAD30567

P577

Q35544697-AC027698-1557-4732-B3D4-8F9D2E11C828

P5875

Q35544697-01D82004-B30E-4E4D-BAB0-D894EDE89001

P6179

Q35544697-7F4632F9-8D1A-4D0A-99A7-3C4403477554

P698

Q35544697-06844DAD-CDD7-492A-9638-6285724B55B4

P932

Q35544697-AD1B805E-1E83-46D0-8456-EC0377B49D31

P356

S13569-015-0026-Y

P1433

Clinical Sarcoma Research

P1476

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.

@en

P2093

Charlotte Benson

http://www.w3.org/2001/XMLSchema#string

Cyril Fisher

http://www.w3.org/2001/XMLSchema#string

Ian Judson

http://www.w3.org/2001/XMLSchema#string

Jonathan Noujaim

http://www.w3.org/2001/XMLSchema#string

Juan Martin-Liberal

http://www.w3.org/2001/XMLSchema#string

Komel Khabra

http://www.w3.org/2001/XMLSchema#string

Maria Ifijen

http://www.w3.org/2001/XMLSchema#string

Nadia Yousaf

http://www.w3.org/2001/XMLSchema#string

Omar Al Muderis

http://www.w3.org/2001/XMLSchema#string

Samuel Harris

http://www.w3.org/2001/XMLSchema#string

P2860

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

Risk factors for doxorubicin-induced congestive heart failure

Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Use of geriatric assessment for older adults in the oncology setting: a systematic review.

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Factors influencing treatment patterns of breast cancer patients age 75 and older.

P2888

s13569-015-0026-y

P304

10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13569-015-0026-Y

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275661522

http://www.w3.org/2001/XMLSchema#string

P6179

1027433702

http://www.w3.org/2001/XMLSchema#string

P698

25922657

http://www.w3.org/2001/XMLSchema#string

P932

4411764

http://www.w3.org/2001/XMLSchema#string